AU1092800A - N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists - Google Patents

N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists

Info

Publication number
AU1092800A
AU1092800A AU10928/00A AU1092800A AU1092800A AU 1092800 A AU1092800 A AU 1092800A AU 10928/00 A AU10928/00 A AU 10928/00A AU 1092800 A AU1092800 A AU 1092800A AU 1092800 A AU1092800 A AU 1092800A
Authority
AU
Australia
Prior art keywords
imidazolylalkyl
histamine
cyclic amines
substituted cyclic
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10928/00A
Other languages
English (en)
Inventor
Adriano Afonso
Stuart B Rosenblum
Ronald Wolin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU1092800A publication Critical patent/AU1092800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10928/00A 1998-10-16 1999-10-15 N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists Abandoned AU1092800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09173642 1998-10-16
US09/173,642 US6133291A (en) 1998-10-16 1998-10-16 N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
PCT/US1999/021461 WO2000023438A1 (en) 1998-10-16 1999-10-15 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists

Publications (1)

Publication Number Publication Date
AU1092800A true AU1092800A (en) 2000-05-08

Family

ID=22632924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10928/00A Abandoned AU1092800A (en) 1998-10-16 1999-10-15 N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists

Country Status (10)

Country Link
US (1) US6133291A (cg-RX-API-DMAC7.html)
EP (1) EP1121354B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002527513A (cg-RX-API-DMAC7.html)
CN (1) CN1198817C (cg-RX-API-DMAC7.html)
AT (1) ATE284398T1 (cg-RX-API-DMAC7.html)
AU (1) AU1092800A (cg-RX-API-DMAC7.html)
CA (1) CA2346436A1 (cg-RX-API-DMAC7.html)
DE (1) DE69922528T2 (cg-RX-API-DMAC7.html)
ES (1) ES2229782T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000023438A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
AU2001238690A1 (en) 2000-03-14 2001-09-24 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
WO2001092226A1 (en) * 2000-05-25 2001-12-06 Sepracor, Inc. Heterocyclic analgesic compounds and method of use thereof
WO2002044141A2 (en) * 2000-09-20 2002-06-06 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
KR100432577B1 (ko) 2002-02-08 2004-05-24 주식회사유한양행 이미다졸 유도체의 제조방법
RU2323935C2 (ru) * 2002-04-18 2008-05-10 Шеринг Корпорейшн Производные бензимидазола, их применение и фармацевтическая композиция на их основе, обладающая свойствами антагониста рецептора гистамина h3
MY135686A (en) * 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
CA2609957A1 (en) * 2005-06-20 2007-01-04 Schering Corporation Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3233077B1 (en) 2014-12-19 2026-05-06 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) * 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
JPS6287573A (ja) * 1985-10-11 1987-04-22 Banyu Pharmaceut Co Ltd 四級アンモニウム塩の製造法
GB8916947D0 (en) * 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
GB9115740D0 (en) * 1991-07-20 1991-09-04 Smithkline Beecham Plc Medicaments
NZ246434A (en) * 1991-12-18 1996-02-27 Schering Corp Imidazoylalkyl substituted by a six membered nitrogen containing heterocycle; pharmaceutical compositions and preparatory methods
DE69212844T2 (de) * 1991-12-18 1997-01-09 Schering Corp., Kenilworth, N.J. Imidazolyl oder imidazolylalkyl substituiert mit einem 4- oder 5-gliedrigen stickstoff enthaltenden heterozyklischen ring
AU662588B2 (en) * 1991-12-18 1995-09-07 Schering Corporation Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine H3 agonists/antagonists
US5807872A (en) * 1992-12-16 1998-09-15 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
FI92843C (fi) * 1993-02-25 1995-01-10 Eija Anitta Maeensivu Uusi menetelmä optisesti aktiivisten glyserolijohdannaisten valmistamiseksi
NZ276883A (en) * 1993-11-15 1998-08-26 Schering Corp 1h-imidazol-4-yl)alkyl]benzene derivatives
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
CA2222652A1 (en) * 1995-06-07 1996-12-19 Gliatech, Inc. 1h-4(5)-substituted imidazole derivatives

Also Published As

Publication number Publication date
ATE284398T1 (de) 2004-12-15
CN1198817C (zh) 2005-04-27
DE69922528T2 (de) 2005-12-15
EP1121354A1 (en) 2001-08-08
ES2229782T3 (es) 2005-04-16
CA2346436A1 (en) 2000-04-27
WO2000023438A1 (en) 2000-04-27
CN1323302A (zh) 2001-11-21
US6133291A (en) 2000-10-17
JP2002527513A (ja) 2002-08-27
DE69922528D1 (de) 2005-01-13
EP1121354B1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
WO2002076925A3 (en) Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
ATE284398T1 (de) N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten
YU42402A (sh) Jedinjenja karbamida koja imaju antagonističku aktivnost na muskarinski receptor
EP0903349A3 (en) CCR-3 receptor antagonists
MXPA04000707A (es) Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas.
TW200517388A (en) Thiazole derivatives as cannabinoid receptor modulators
MXPA02005596A (es) Derivados de carbamato con actividad antagonista para el rerceptor muscarinico.
GB0115862D0 (en) Compounds
CR9304A (es) Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos
NO20033732L (no) N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser.
MY138220A (en) ARYL ANILINE ß2 ADRENERGIC RECEPTOR AGONISTS
WO2002072536A8 (en) Urea derivatives having vanilloid receptor (vr1) antagonist activity
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
BRPI0409958A (pt) quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso
DE60015187D1 (de) Urotensin-ii rezeptorantagonisten
WO2002044141A3 (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
MY117975A (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
EA200300850A1 (ru) Применение антагонистов рецептора gal3 при лечении депрессии и/или тревоги и соединения, полезные в таких способах
SE0001373D0 (sv) NPY Y1 receptor agonists and antagonists
MY120281A (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
MY129677A (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
YU58702A (sh) Postupak za proizvodnju 5-arilnikotinaldehida
PL1668027T3 (pl) Cykliczne peptydy działające jako antagoniści Urotensyny-II

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase